Material Handling Featured Articles
-
FDA Sets Recommendations For Predicting Dangerous Nitrosamine Impurities
10/25/2023
The FDA recently published a final guidance that sets a recommended framework for predicting the potential of nitrosamine drug substance-related impurities.
-
5 Key Considerations For MES Vendor Selection
10/20/2023
Have you made a strategic business decision to implement a manufacturing execution system (MES)? Selecting a MES vendor is a strategic and thoughtful process. With these five considerations, you can give some thought to how MES fits into your enterprise landscape and your business requirements.
-
The Right Polymers For Your Modified Release Multiparticulate Capsule
10/9/2023
Pharma companies aiming to tech transfer or scale-up modified release formulations often encounter hurdles when the formulation is not robust. Review how to select the right polymers and ensure you have a robust formulation strategy.
-
Supply Chain Sustainability: Manufacturing Of RSMs And KSMs
10/3/2023
De-risking RSM and KSM procurement can be accomplished via several means, but local sourcing of raw materials and in-house production have proven tremendously effective.
-
How To Lose A Batch In 10 Days
9/25/2023
Inspired by the rom com How to Lose a Guy in 10 Days, this article spotlights the critical missteps that could lead you to lose a batch during the manufacturing process. By identifying these pitfalls, the author guides you toward best practices that will not only save your batches but also improve the quality, efficiency, and reliability of your operations.
-
Have You Adopted A Manufacturing Execution System Yet?
9/7/2023
Manufacturing execution systems (MES) have become crucial in managing bio/pharmaceutical operations to ensure compliance and promote efficiency. This article shares the benefits of adopting a MES, the three deployment options, manufacturing applications for MES, and more.
-
FDA Issues Second DSCSA Warning Letter — What Does This Mean?
8/16/2023
In June 2023, shortly before final requirements of the Drug Supply Chain Security Act (DSCSA) must be met come November, the FDA issued a warning letter to Safe Chain Solutions, LLC addressing DSCSA violations related to repeated instances of distributing costly counterfeit antiviral drugs that Safe Chain had sourced from unauthorized trading partners. Let's look more closely at the emerging themes so that you can avoid a similar warning letter.
-
Financial Leadership Of Strategic Procurement: 4 Foundational Steps
8/2/2023
Efficiently managing a diverse supply base is crucial for drug companies to maintain growth, profitability, and compliance. While the procurement function can be organized under various executives, the relationship between the CFO, procurement, legal, and buying departments is very important.
-
Tablet Tooling Nutraceutical Products
7/25/2023
How can you reduce tooling wear and problems caused by abrasive ingredients during your tablet manufacturing process?
-
Intro to USP <1062> — What Is Tabletability?
7/20/2023
What is tabletability, and why is it important for creating tablets that can survive the journey from manufacturing to packaging?